WO2017142368A3 - Composition for preventing and treating allergic or inflammatory skin disease - Google Patents
Composition for preventing and treating allergic or inflammatory skin disease Download PDFInfo
- Publication number
- WO2017142368A3 WO2017142368A3 PCT/KR2017/001808 KR2017001808W WO2017142368A3 WO 2017142368 A3 WO2017142368 A3 WO 2017142368A3 KR 2017001808 W KR2017001808 W KR 2017001808W WO 2017142368 A3 WO2017142368 A3 WO 2017142368A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preventing
- composition
- inflammatory skin
- treating allergic
- skin disease
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a composition for preventing or treating allergic or inflammatory disease, comprising an NED19, bromo-cyclic ADP-ribose or emodin as an effective ingredient. The NED19, bromo-cyclic ADP-ribose and emodin of the present invention have an excellent effect in preventing and treating various allergic or inflammatory skin diseases including histamine-dependent and histamine-independent itching and atopic dermatitis itching, and thus can be variously used in medicines, external skin preparations, foods, cosmetics, and the like.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160019807 | 2016-02-19 | ||
KR10-2016-0019807 | 2016-02-19 | ||
KR1020170021592A KR20170098182A (en) | 2016-02-19 | 2017-02-17 | Composition for preventing or treating allergic or inflammatory skin disease |
KR10-2017-0021592 | 2017-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017142368A2 WO2017142368A2 (en) | 2017-08-24 |
WO2017142368A3 true WO2017142368A3 (en) | 2018-09-07 |
Family
ID=59625237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/001808 WO2017142368A2 (en) | 2016-02-19 | 2017-02-17 | Composition for preventing and treating allergic or inflammatory skin disease |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017142368A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3527227A4 (en) * | 2016-10-11 | 2020-09-16 | Industrial Cooperation Foundation Chonbuk National University | Use of cadpr or naadp antagonists |
CN116747213A (en) * | 2023-06-30 | 2023-09-15 | 大连医科大学附属第一医院 | Application of emodin in inhibiting sebaceous gland synthesis and secretion |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037089A1 (en) * | 1998-12-18 | 2000-06-29 | University Of Bath | Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
KR100812596B1 (en) * | 2006-12-15 | 2008-03-13 | 바이오스펙트럼 주식회사 | Compositions comprising compounds of natural origin for damaged skin |
KR100832332B1 (en) * | 2007-02-12 | 2008-05-26 | 바이오스펙트럼 주식회사 | Compositions for ameliorating symptom of atopic dermatitis |
WO2009156724A2 (en) * | 2008-06-25 | 2009-12-30 | Isis Innovation Limited | Novel compounds |
-
2017
- 2017-02-17 WO PCT/KR2017/001808 patent/WO2017142368A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037089A1 (en) * | 1998-12-18 | 2000-06-29 | University Of Bath | Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
KR100812596B1 (en) * | 2006-12-15 | 2008-03-13 | 바이오스펙트럼 주식회사 | Compositions comprising compounds of natural origin for damaged skin |
KR100832332B1 (en) * | 2007-02-12 | 2008-05-26 | 바이오스펙트럼 주식회사 | Compositions for ameliorating symptom of atopic dermatitis |
WO2009156724A2 (en) * | 2008-06-25 | 2009-12-30 | Isis Innovation Limited | Novel compounds |
Non-Patent Citations (2)
Title |
---|
LU: "Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation", BIOCHEMICAL PHARMACOLOGY, vol. 82, 2011, pages 1700 - 1708, XP028329281, DOI: doi:10.1016/j.bcp.2011.08.022 * |
WANG WEIMIN ET AL.: "Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells", PHARMACOLOGICAL REPORTS, vol. 64, 2012, pages 1216 - 1222, XP055601330, ISSN: 1734-1140 * |
Also Published As
Publication number | Publication date |
---|---|
WO2017142368A2 (en) | 2017-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL255203B (en) | Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders | |
WO2016172658A3 (en) | Microbiome regulators and related uses thereof | |
EP3684353A4 (en) | Topical formulations of cannabinoids and use thereof in the treatment of pain | |
EP3668497A4 (en) | Methods and compositions for the treatment of diseases associated with cancer, inflammation, or immune response | |
EP4219713A3 (en) | Products and compositions | |
WO2015073587A3 (en) | Synthetic membrane-receiver complexes | |
WO2017207481A8 (en) | Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals | |
SI3377637T1 (en) | Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin | |
WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
EP3483256A4 (en) | Akkermansia muciniphila strain having effect of preventing or treating degenerative brain diseases or metabolic diseases, and use thereof | |
WO2016210384A3 (en) | Bacteria engineered to treat metabolic diseases | |
EP4299122A3 (en) | Compositions and methods for treating skin and mucous membrane diseases | |
PH12017500706A1 (en) | Composition containing extract or fraction of genus justicia plant | |
AU2018264384A1 (en) | Solid forms of berberine ursodeoxycholate and compositions and methods thereof | |
WO2016200614A3 (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
WO2017139697A8 (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
MX370958B (en) | Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin. | |
EP3582768A4 (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
MX2018008645A (en) | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives. | |
EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
WO2017121646A8 (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
WO2015106215A3 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
WO2017142368A3 (en) | Composition for preventing and treating allergic or inflammatory skin disease | |
WO2013153108A3 (en) | Embelia concinna extract comprising flavonoids in cosmetic and pharmaceutical compositions | |
WO2018081183A3 (en) | Maca compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17753529 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17753529 Country of ref document: EP Kind code of ref document: A2 |